S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
S&P 500   3,849.62
DOW   30,937.04
QQQ   328.59
Log in
FRA:FRE

Fresenius SE & Co. KGaA (FRE.F) Stock Forecast, Price & News

€38.28
+0.71 (+1.89 %)
(As of 01/26/2021 12:00 AM ET)
Add
Compare
Today's Range
€37.60
Now: €38.28
€38.71
50-Day Range
€36.85
MA: €38.40
€40.10
52-Week Range
€60.16
Now: €38.28
€80.00
Volume1.60 million shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Fresenius SE & Co. KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment offers dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment specializes in the therapy and care of chronically and critically ill patients. This segment offers IV drugs, including intravenously administered generic anesthetics, analgesics, anti-infectives, and drugs for the treatment of oncological and other critical diseases; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; infusion and nutrition pumps, as well as consumables; and products that are used in the collection and processing of blood components, as well as in transfusion medicine and cell therapy. As of December 31, 2019, this segment operated 86 hospitals, approximately 125 outpatient clinics, and 8 prevention centers. The Fresenius Vamed segment manages projects and provides services for hospitals and other health care facilities. This segment offers project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. Fresenius SE & Co. KGaA has a strategic partnership with Humacyte Inc. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
Fresenius SE & Co. KGaA (FRE.F) logo

MarketRank

Overall MarketRank

1.51 out of 5 stars

Analyst Opinion: 4.4Community Rank: 3.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Medical Care Facilities
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+49-6172-6080
Employees309,114
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable
€38.28
+0.71 (+1.89 %)
(As of 01/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive FRE News and Ratings via Email

Sign-up to receive the latest news and ratings for FRE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Fresenius SE & Co. KGaA (FRE.F) (FRA:FRE) Frequently Asked Questions

How has Fresenius SE & Co. KGaA (FRE.F)'s stock price been impacted by Coronavirus?

Fresenius SE & Co. KGaA (FRE.F)'s stock was trading at €36.02 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, FRE shares have increased by 6.3% and is now trading at €38.28.
View which stocks have been most impacted by COVID-19
.

Is Fresenius SE & Co. KGaA (FRE.F) a buy right now?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius SE & Co. KGaA (FRE.F) in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Fresenius SE & Co. KGaA (FRE.F) stock.
View analyst ratings for Fresenius SE & Co. KGaA (FRE.F)
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Fresenius SE & Co. KGaA (FRE.F)?

Wall Street analysts have given Fresenius SE & Co. KGaA (FRE.F) a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Fresenius SE & Co. KGaA (FRE.F) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

What price target have analysts set for FRE?

15 Wall Street analysts have issued twelve-month price targets for Fresenius SE & Co. KGaA (FRE.F)'s stock. Their forecasts range from €33.00 to €65.00. On average, they anticipate Fresenius SE & Co. KGaA (FRE.F)'s share price to reach €49.49 in the next year. This suggests a possible upside of 29.3% from the stock's current price.
View analysts' price targets for Fresenius SE & Co. KGaA (FRE.F)
or view Wall Street analyst' top-rated stocks.

Who are some of Fresenius SE & Co. KGaA (FRE.F)'s key competitors?

What other stocks do shareholders of Fresenius SE & Co. KGaA (FRE.F) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius SE & Co. KGaA (FRE.F) investors own include Illumina (ILMN), Daimler AG (DAI.F) (DAI), Endologix (ELGX), Allianz SE (ALV.F) (ALV), (APA), Cambrex (CBM), Linde plc (LIN.F) (LIN), Alibaba Group (BABA), General Electric (GE) and HeidelbergCement AG (HEI.F) (HEI).

Who are Fresenius SE & Co. KGaA (FRE.F)'s key executives?

Fresenius SE & Co. KGaA (FRE.F)'s management team includes the following people:
  • Mr. Stephan Sturm, CEO, Pres & Chairman of Management Board - Fresenius Management SE (Age 58, Pay $3.49M)
  • Ms. Rachel Clare Empey, CFO & Member of Management Board - Fresenius Management SE (Age 45, Pay $1.61M)
  • Dr. Francesco De Meo, Member of Management Board - Fresenius Management SE (Age 58, Pay $2.4M)
  • Dr. Ernst Wastler, Member of Management Board - Fresenius Management SE (Age 63, Pay $1.43M)
  • Mr. Mats Christer Henriksson, Member of Management Board - Fresenius Management SE (Age 54, Pay $2.36M)
  • Mr. Rice Powell, Member of Management Board - Fresenius Management SE (Age 66, Pay $4.63M)
  • Dr. Sebastian Biedenkopf, Chief Legal & Compliance Officer, Insurance, HR, Labor Relations Director and Member of Mgmt. Board (Age 57)
  • Mr. Markus Georgi, Sr. VP of Investor Relations

What is Fresenius SE & Co. KGaA (FRE.F)'s stock symbol?

Fresenius SE & Co. KGaA (FRE.F) trades on the FRA under the ticker symbol "FRE."

What is Fresenius SE & Co. KGaA (FRE.F)'s stock price today?

One share of FRE stock can currently be purchased for approximately €38.28.

What is Fresenius SE & Co. KGaA (FRE.F)'s official website?

The official website for Fresenius SE & Co. KGaA (FRE.F) is www.fresenius.de.

How can I contact Fresenius SE & Co. KGaA (FRE.F)?

Fresenius SE & Co. KGaA (FRE.F)'s mailing address is Else-Kroener-Str. 1, BAD HOMBURG VOR DER HOEHE, 61352, Germany. The company can be reached via phone at +49-6172-6080.

This page was last updated on 1/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.